ArticleCase reports in ophthalmology

Sight-Threatening Immune Retinopathy Developing Secondary to Durvalumab Treatment of Small-Cell Lung Cancer: A Case Report.

Doah Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.